Skip to main content

Month: May 2024

Evome Medical Technologies Announces Biodex Generated 100% Sales Growth Comparing April 2024 to January 2024, Plans to Shed Remaining Non-Core Units to Pay Off Remaining Acquisition Debt

Posting Q1 Financials, Provides Updates on Strong Q2 NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) — Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) today reported continued progress on its turn-around plan. Evome has grown revenue at its core business unit, Biodex Medical Systems, Inc. (“Biodex”), while reducing total debt significantly for the third straight quarter. The Company announced it generated 100% revenue growth in its Biodex business unit in April 2024 compared to January 2024 as a result of the final reorganization of Biodex in January 2024. While the retooling impacted the unaudited financial results for the first quarter ending March 31, 2024, to be filed today, the Company is providing details indicating a strong second quarter to date. In terms of revenue growth initiatives, the Company announces...

Continue reading

PodcastOne (Nasdaq: PODC) Reports Record Fiscal Year 2024 Results

Record Revenue of $43.3M for FY 2024, $11.7M for Q4 FY 2024 Adjusted EBITDA* of $0.7M for FY 2024, $258K for Q4 FY 2024 Financial Highlights:Increased Shareholders’ Equity by $9M from Prior Fiscal Year Reduced Liabilities by $13M from Prior Fiscal Year Extinguished All Debt, Repaying $3M in Cash and Converting $7M into Shares of Common Stock at $3 Per ShareRaises FY 2025 Revenue Guidance to $51-56M LiveOne (Nasdaq: LVO) Acquired 159,000 PODC Shares at a Price of $3 Per Share During March 2024 and Continues to Acquire Additional Shares This Quarter Special Shareholders Call: Senior Management to Host a Special Shareholders Call at 10:00 A.M. ET on Wednesday, June 5, 2024LOS ANGELES, May 30, 2024 (GLOBE NEWSWIRE) — PodcastOne (Nasdaq: PODC), a leading podcast platform and a subsidiary of LiveOne (Nasdaq: LVO), announced...

Continue reading

Enrollment in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis to Begin at Tufts Medical Center; First Study of Its Kind

60 Degrees Pharmaceuticals has entered an agreement with Tufts Medical Center to conduct a clinical trial that will evaluate the safety and efficacy of tafenoquine for the treatment of babesiosis in humans The study will be the world’s first clinical trial to evaluate tafenoquine in human babesiosis patients Enrollment will begin after a site initiation visit in Boston on June 13, 2024 Agreements are being negotiated with two other prominent university hospitals to expand recruitment in the Northeast U.S. where the incidence of babesiosis has been increasing; babesiosis, a tick-borne and potentially life-threatening illness, is an orphan disease Case studies in the medical literature suggest that tafenoquine may be a promising alternative for the treatment of some patients hospitalized with relapsing babesiosisWASHINGTON, May 30, 2024...

Continue reading

CF Energy Announces Financial Results For The three-month period March 31, 2024

TORONTO, May 30, 2024 (GLOBE NEWSWIRE) — CF Energy Corp. (TSX-V: CFY) (“CF Energy” or the “Company”, together with its subsidiaries, the “Group”), an energy provider in the People’s Republic of China (the ”PRC” or “China”), announces that the Company has filed its unaudited condensed interim consolidated financial results for the three-month period ended March 31, 2024. Results for the three-month period ended March 31, 2024 (“Q1 2024”) Continuing Operations                     In millions Q1 2024   Q1 2023   Change   %   Q1 2024   Q1 2023   Change    (except for % figures) RMB   RMB   RMB       CAD   CAD   CAD    Continuing Operations                    Revenue 149.0   93.8   55.2   59 % 28.0   18.5   9.5    Gross Profit 32.7   28.2   4.5   16 % 6.1   5.6   0.5    Gross Profit Margin 21.9 % 30.1 % -8.2 %              Net...

Continue reading

Cerro Grande Mining Corporation Announces its Second Fiscal Quarter ended March 31, 2024 results compared to the same period in 2023

TORONTO, May 30, 2024 (GLOBE NEWSWIRE) — Cerro Grande Mining Corporation (the “Company” or “CEG”) (CSE:CEG) reported its unaudited results for the second fiscal quarter ended March 31, 2024 compared to the same quarter in 2023. These financial statements and MD&A have been filed on SEDAR and the Company refers the reader to those materials for additional information. Cerro Grande Mining Corporation is an exploration and development company with properties and activities currently focused in Chile. Cautionary Statement on Forward-looking Information: This news release contains “forward-looking information”, which may include, but is not limited to, statements with respect to the future financial or operating performance of CEG. Often, but not always, forward-looking statements can be identified by the use of words...

Continue reading

Greenridge Exploration Announces Acquisition of the Carpenter Lake Uranium Project in the Athabasca Basin with Multiple High Priority Targets

HighlightsThe Carpenter Lake Uranium Project is fully permitted for an extensive drilling program.The Project hosts extensive previous exploration with multiple high priority targets across the Cable Bay Shear Zone.The Project covers 13,387 hectares of the Cable Bay Shear Zone parallel to the Virgin River Shear Zone.1Cameco’s Centennial deposit is located 45km southeast of the Project.1The Project is 95 km west of Cameco’s past producing Key Lake uranium mine which extracted over 220 million lbs. of uranium by open pit at an average grade of 2.3% U3O8 from 1983-1997.1Historical sampling from 2014 reveal multiple radioactive boulders on the Project with three (3) over 1,000 ppm uranium, and up to 1,550 ppm uranium.VANCOUVER, British Columbia, May 30, 2024 (GLOBE NEWSWIRE) — Greenridge Exploration Inc. (“Greenridge”...

Continue reading

PyroGenesis Announces Intent to Exercise Option to Purchase 50% of HPQ Silica Polvere

Company to convert annual royalty rights into ownership interest MONTREAL, May 30, 2024 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY), a high-tech company (the “Company” or “PyroGenesis”) that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions which are geared to reduce greenhouse gases (GHG) and address environmental pollutants, is pleased to announce that the Company has notified HPQ Silicon Inc. (“HPQ”) of its intent to exercise its right to convert its annual royalty rights into a 50% ownership of HPQ Silica Polvere Inc. (“HPQ Polvere”), a wholly-owned subsidiary of HPQ. As previously discussed in the Company’s news releases dated July 6, 2021 and March 12, 2024, PyroGenesis and HPQ Polvere are parties to a Development...

Continue reading

Village Farms International Boosts Ownership in Fast-Growing Rose LifeScience

– Purchase is Immediately Accretive to Adjusted EBITDA, Net Income – VANCOUVER, British Columbia and ORLANDO, Fla., May 30, 2024 (GLOBE NEWSWIRE) — Village Farms International, Inc. (“Village Farms” or “the Company”) (NASDAQ: VFF) today announces it has increased its ownership of Quebec-based Rose LifeScience Inc. (“Rose”) by 10% to hold an 80% interest. “Village Farms’ initial 70% acquisition of Rose stands out as one of the most complementary business combinations to date in the Canadian cannabis industry. Since late 2021, the combination of the experienced teams at Rose and Pure Sunfarms have driven Village Farms into the number two share rank nationally as Rose sales grew more than 300% to reach the number two share rank in Quebec, with each closing the gap to number one,” said Michael DeGiglio, President and Chief Executive...

Continue reading

AGF Investments Announces Uncapping of AGF Fixed Income Plus Class Series MF and Q

TORONTO, May 30, 2024 (GLOBE NEWSWIRE) — AGF Investments Inc. (AGF Investments) (TSX:AGF.B) today announced the uncapping of AGF Fixed Income Plus Class MF Series and Q Series to new investors, effective June 4, 2023. The series were previously capped in 2023, though have remained in existence and available for investment by existing investors during the interim time period. AGF Investments continually reviews its product line-up to ensure its offerings are responsive to market trends and the evolving needs of clients. About AGF Management Limited Founded in 1957, AGF Management Limited (AGF) is an independent and globally diverse asset management firm. Our companies deliver excellence in investing in the public and private markets through three business lines: AGF Investments, AGF Capital Partners and AGF Private Wealth. AGF brings...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.